Acute Intoxication following Dimethyltryptamine Ingestion
Matthew H. Bilhimer, Rachel F. Schult, Kristan V. Higgs, Timothy J. Wiegand, Rachel Gorodetsky, Nicole M. Acquisto
Case Reports in Emergency Medicine 2018 DOI: 10.1155/2018/3452691 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Patient with history of schizophrenia who ingested ayahuasca tea |
| Intervention | Ayahuasca tea |
| Topics | 5-MeO-DMT DMT |
| Keywords | Ingestion |
| Citations | 26 |
| Key findings | Ayahuasca ingestion in a patient with schizophrenia resulted in personal injury and property damage, underscoring severe adverse effects in vulnerable populations. |
Abstract
Ayahuasca is a hallucinogenic tea that is most commonly comprised of the vine Banisteriopsis caapi alone or in combination with other plants such as Psychotria viridis . This concoction results in an orally active form of dimethyltryptamine (DMT), a hallucinogenic amine. Despite use in South America as a medicinal agent and component in religious ceremonies, interest in its recreational use and spiritual effects has led to increased use in the United States. We describe a unique case following ingestion of ayahuasca tea in a patient with history of schizophrenia resulting in personal injury and property damage. A review of ayahuasca toxicity and evaluation of serious adverse effects is also presented.
Comparable studies
Other case reports and case series on DMT, most cited first.
Citations in the library
Cited by 23
- Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS global public health 2022
- Toxicology and Analysis of Psychoactive Tryptamines International Journal of Molecular Sciences December 4, 2020
- N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine Human Psychopharmacology: Clinical and Experimental February 17, 2022
- A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond Biotechnology Advances August 31, 2023
- Ayahuasca and the traveller: A scoping review of risks and possible benefits Travel Medicine and Infectious Disease November 1, 2021
and 18 more in the library
Cites 15
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Therapeutic Advances in Psychopharmacology March 18, 2016
- Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers Psychopharmacology February 22, 2001
- The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology August 1, 2015
- Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction December 20, 2006
- Ayahuasca: Pharmacology, neuroscience and therapeutic potential Brain Research Bulletin March 11, 2016
and 10 more in the library